AOD9604 is a synthetic peptide that consist 14 amino acids. Also called as tyr-somatostatin, AOD9604 stimulates lipolysis and suppress lipogenesis without influencing growth or causing insulin resistance. The compound is regarded as a growth hormone analogue. Experimental studies were conducted by the scientists at Monash University to investigate the effects of the compound on obesity. The researchers found that the compound selectively target obese fat cells but not lean fat cells. Being rich in proline and proteases, AOD9604 exerts several cellular changes in cytoplasm. The hypolipidemic property of the investigative compound is being studied by the research community. The compound’s molecular weight is 1815.1 and molecular formula is C78H13O23S2.

The studies carried on the peptide AOD9604 for their ability to increase blood glucose and sustain blood insulin, which in turn helps in reduction of lipogenesis a process, which induces depositing of fats on the visceral and peripheral organs. The informational sequence is highly influential in presenting regions of high protein accessibility to the receptors. Research shows that the HGH fragment releasing fats are inhibited by the introduction of the polypeptide, moreover it does not induce growth or change food consumption.   AOD9604 increases muscle mass, reduce excess adipose tissues in the abdominal area and increases the lipid content in the body. The functionality of the polypeptide is largely dependent on the informational sequence and physical configuration. Any conformational change on the high cysteine and proline region will affect the binding affinity of the molecule as well as its potency. Peripheral binding is influenced by the two domains, which serve as hinge on the membrane.

AOD9604 is a synthetic peptide that consists of 14 amino acids. Also known as tyr-somatostatin, AOD9604 stimulates lipolysis and suppress lipogenesis without influencing growth or causing insulin resistance. The compound is regarded as a growth hormone analogue. Experimental studies were conducted by the scientists at Monash University to investigate the effects of the compound on obesity. The researchers found that the compound selectively targets obese fat cells but not lean fat cells. Being rich in proline and proteases, AOD9604 exerts several cellular changes in cytoplasm. The hypolipidemic property of the investigative compound is being studied by the research community. The compound’s molecular weight is 1815.1 Daltons and molecular formula is C78H13O23S2.